🌟 Our Bonn-based team has officially kicked off the winter season with a new addition! Please welcome Dr. Christopher Jahn, the newest member of our investment team! 🎉 Christopher brings an exceptional blend of expertise in biological systems and a passion for driving innovation in #biotech and #medtech. Based in Cologne, Christopher enjoys spending time with his two daughters and staying active through sports. He’s a big fan of ball games—especially soccer—and also loves snowboarding and practicing Jiu-Jitsu to unwind. 🥋 🧪Before joining DTCF in December 2024, Christopher was part of TVF | TechVision Fonds Fund, where he managed investments and portfolio companies in #LifeSciences. With a PhD in Molecular Medicine focused on tissue regeneration and a Certified Private Equity Analyst credential from Technische Universität München, his academic and professional background adds incredible depth to our team. We’re thrilled to have you on board, Christopher, and we can’t wait to see the impact you’ll make! 🚀 Elisabeth Schrey Tobias Faupel Torsten Löffler Günther Bogenrieder Lena Stache Cristina Doumitrachko Jana Kutter Tobias Weissgerber Jonas Sommer Dr. Anne-Kathrin Hinze Dr. Markus Düttmann Stephanie L. Stein
Freue mich wieder mit Dir in einem Team zu sein!
Weiterhin einen guten Start Christopher Jahn - mit Dir als dem ersten Biologen in unserem Team wird unser Life Science Coverage auf jeden Fall steigen!
Jetzt schon eine Bereicherung für Bonn!🚀 Willkommen im #Team! ❤️
Willkommen im Team, Christopher 🥳
"Welcome aboard, Christopher! 🎉 It was a pleasure meeting you during our team days last week—looking forward to all the exciting biotech and medtech deals you'll be bringing to the portfolio. 🧬
Christopher great to have you in the team! 🚀
Welcome Christopher 🚀🚀 🚀
Welcome to the team, Christopher! 🤗 🚀
Life Science Investor | Venture Capital | Certified Private Equity Analyst | PhD in Molecular Medicine
4dThank you so much for the warm welcome DTCF | DeepTech & Climate Fonds-Team! 🙌 I’m truly excited to join the team and work together to drive innovation in biotech and medtech. 🚀